公开(公告)号：US20140023675A1

公开(公告)日：2014-01-23

申请号：US13977780

申请日：2012-01-03

Applicant: Bruno Lina ,  Olivier Ferraris ,  Ho Hong Hai Vo ,  Francois-Loic Cosset ,  Judit Szecsi ,  Alain Heyraud ,  Hugues Lortat-Jacob ,  Julia Bartoli ,  Rabia Sadir ,  Thierry Livache ,  Benoit Darblade ,  Stephane Havet ,  Silvére Bonnet

Inventor： Bruno Lina ,  Olivier Ferraris ,  Ho Hong Hai Vo ,  Francois-Loic Cosset ,  Judit Szecsi ,  Alain Heyraud ,  Hugues Lortat-Jacob ,  Julia Bartoli ,  Rabia Sadir ,  Thierry Livache ,  Benoit Darblade ,  Stephane Havet ,  Silvére Bonnet

IPC: A61K31/737

CPC classification number: A61K31/737 ,  A61K31/715 ,  A61K36/05 ,  A61K36/888

Abstract: The present invention relates to polysaccharides selected from sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans intended to be used as a drug for the preventive or curative treatment of an influenza virus, as well as to the pharmaceutical compositions including, in particular in combination with at least one pharmaceutically acceptable carrier: either an extract of Codium fragile, including sulphated arabinogalactans, or an extract of Zostera marina or Lemna minor, including apiogalacturonans, or an extract of Caulerpa racemosa, including sulphated heteroglycans.

Abstract translation: 本发明涉及旨在用作预防或治疗性流感病毒的药物的硫酸化阿拉伯半乳聚糖，阿片半乳糖聚糖和硫酸化异糖聚糖的多糖，以及该药物组合物，特别是与至少一种 药学上可接受的载体：脆弱的Codium的提取物，包括硫酸化的阿拉伯半乳聚糖，或Zostera marina或Lemna minor的提取物，包括半乳糖醛酸聚糖或包括硫酸化杂聚糖的Caulerpa racemosa的提取物。